4//SEC Filing
Nolan Garry Ph.D. 4
Accession 0001104659-22-100936
CIK 0001711933other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 7:07 PM ET
Size
5.0 KB
Accession
0001104659-22-100936
Insider Transaction Report
Form 4
Nolan Garry Ph.D.
Director
Transactions
- Sale
Common Stock
2022-09-14$13.26/sh−8,305$110,084→ 622,788 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.36, inclusive. The reporting person undertakes to provide to Akoya Biosciences, Inc., any security holder of Akoya Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
Documents
Issuer
Akoya Biosciences, Inc.
CIK 0001711933
Entity typeother
Related Parties
1- filerCIK 0001857405
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 7:07 PM ET
- Size
- 5.0 KB